Profile
Younok Dumortier Shin served as Vice President & Managing Director at Dermelix Biotherapeutics, LLC.
She was also the Chief Technology Officer at Avalo Therapeutics, Inc. from 2020 to 2022.
She holds a graduate and doctorate degree from McGill University, an MBA from Babson College, and an undergraduate degree from the University of British Columbia.
Former positions of Younok Dumortier Shin
| Companies | Position | End |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/01/2022 |
Dermelix Biotherapeutics, Llc
 Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Dermelix Biotherapeutics, LLC is a non-clinical stage biopharmaceutical company that specializes in developing treatments for patients with rare genetic skin diseases. Dermelix Biotherapeutics is based in Albany, NY. The private company's focus is on delivering effective therapies to those who suffer from these conditions. | Corporate Officer/Principal | - |
Training of Younok Dumortier Shin
| McGill University | Doctorate Degree |
| Babson College | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Dermelix Biotherapeutics, Llc
Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Dermelix Biotherapeutics, LLC is a non-clinical stage biopharmaceutical company that specializes in developing treatments for patients with rare genetic skin diseases. Dermelix Biotherapeutics is based in Albany, NY. The private company's focus is on delivering effective therapies to those who suffer from these conditions. | Commercial Services |
- Stock Market
- Insiders
- Younok Dumortier Shin
